St. Jude Medical announces PAVE and DINAMIT clinical tri...( l trials have generally focused on pati...),Health

l trials have generally focused on patients whose AMI event occurred greater than 6 months prior to their ICD implant. The DINAMIT results demonstrate that the overall mortality benefits of ICD therapy in a post-AMI patient population do not extend to those who receive an ICD shortly after their AMI event, as other causes of death offset the observed decrease in arrhythmic mortality.

Further analysis of the data from these studies will attempt to find evidence of other factors which lead to the differences in non-arrhythmic deaths.

ICDs are medical devices implanted under the skin that are designed to deliver a range of electrical therapies, from mild stimulation to more powerful shocks, to treat patients with ventricular tachycardia (VT) and ventricular fibrillation (VF). These potentially lethal heart rhythms commonly contribute to sudden cardiac death (SCD), a condition that kills over 400,000 Americans each year.

'"/>

Contact: Mechal Weiss
mechal.weiss@edelman.com
212-642-7731
Edelman Public Relations
8-Mar-2004


Page: 1 2 3 4
Related medicine news :

1. Medically supervised drug injection facilities safer for users
2. Medical molecules designed to respond to visible light that can penetrate tissue
3. Philanthropist Paul F. Glenn launches labs for aging research at Harvard Medical School
4. UCLA Medical Center becomes first hospital to introduce remote presence robots in ICU
5. New data on Orqis Medicals Cancion CRS to be reported at ACC
6. Medical technologies may hinder rather than help newborn survival
7. Medical meeting to feature research findings and disease prevention and health promotion sessions
8. LA BioMed Medical/Research briefs January 2005
9. Medical negligence system is secretive, unaccountable and unregulated
10. Dartmouth Medical School receives $1.6 million in AIDS funding
11. LA BioMed Medical/Research Briefs December 2004